Most Read News

At meeting held on 06 May 2022

Lupin today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Iloperidone Tablets, 1 mg, 2. mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg to market a generic equivalent of Fanapt? Tablets, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg of […]

Sales decline 2.89% to Rs 3119.95 crore

At meeting held on 06 May 2022

Dr Lal Pathlabs has allotted 7000 equity shares under ESOP. Pursuant to the above allotment, the paid-up equity share capital of the company stand increased from Rs 83,34,48,770/- divided into 8,33,44,877 equity shares of Rs 10 /-each to Rs 83,35,18,770/- divided into 8,33,51,877 equity shares of INR 10/- each.Powered by Capital Market – Live News

Record date is 18 May 2022

With effect from 06 May 2022

Ceat Ltd reported 13.2% growth in total revenues yoy for the Mar-22 quarter on consolidated basis at Rs2,591.99cr

Sales rise 37.40% to Rs 328.04 crore

Lupin announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg to market a generic equivalent of Lyrica? Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and […]